|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,862.00 GBX | 0.00% |
|
-2.36% | +7.83% |
| 04-17 | AIM ImmunoTech Starts Late-Stage Trial of Ampligen in Pancreatic Cancer | MT |
| 04-16 | UK stocks close higher as energy sector gains tracking rise in oil prices | RE |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.65% | 1.75% | 25.36x | 5.59x | 5.24x | 14.79x | 15.64x | 312B | ||
| 0.75% | 0.83% | 26.9x | 16.59x | 10.08x | 20.2x | 21.96x | 809B | ||
| 2.27% | 2.37% | 25.14x | 6.31x | 5.78x | 15.69x | 17.38x | 565B | ||
| 3.31% | 3.45% | 23.52x | 140x | 6.29x | 12.77x | 13.13x | 370B | ||
| 2.93% | 3.02% | 27.32x | 5.07x | 4.77x | 14.81x | 17.56x | 285B | ||
| 2.95% | 3.08% | 20.77x | 6.27x | 5.58x | 13.5x | 14.76x | 286B | ||
| 2.88% | 3.08% | 23.43x | 16.7x | 6.05x | 10.71x | 13.74x | 189B | ||
| 4.19% | 4.36% | 12.28x | 5.16x | 4.38x | 9.16x | 10.77x | 180B | ||
| 2.34% | 2.39% | 18.81x | 6.22x | 5.88x | 10.82x | 12.72x | 172B | ||
| 6.44% | 6.42% | 12.34x | 1.75x | 3.27x | 7.88x | 9.23x | 155B | ||
| 4.29% | 4.41% | 12.02x | 5.11x | 3.15x | 8.3x | 9.09x | 120B | ||
| 5.26% | 5.6% | 11.83x | 1.26x | 2.32x | 7.46x | 8.2x | 115B | ||
| 3.29% | 3.57% | 13.43x | 4.4x | 2.85x | 8.27x | 9.42x | 115B | ||
| -.--% | -.--% | 24.89x | 4.92x | 7.5x | 16.9x | 17.47x | 111B | ||
| 1.59% | 1.77% | 27.92x | 6.23x | 9.55x | 17.95x | 18.77x | 88.83B | ||
| 3.54% | 3.6% | 50.53x | 1.25x | 2.84x | 10.48x | 29.74x | 56.04B | ||
| 0.47% | 0.54% | 40.9x | 5.5x | 9.29x | 31.05x | 33.9x | 55.87B | ||
| 0.53% | 1.73% | 20.32x | 1.43x | 1.59x | 7.66x | 13.14x | 47.07B | ||
| Average | 2.7% | 2.89% | 23.21x | 13.32x | 5.36x | 13.24x | 15.92x | 223.9B | |
| Weighted average by Cap. | 2.45% | 2.58% | 23.26x | 20.33x | 6.25x | 14.47x | 16.27x |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















